Safeguarding LTC Pharmacies in the IRA Era: MHA’s Support for LTC Members

The Impact of the IRA on Long-Term Care Pharmacies

The Inflation Reduction Act (IRA) has caused significant shifts in the healthcare and pharmaceutical industries, and a redesign of the Medicare Part D benefit. All of which have significant implications for long-term care (LTC) pharmacies.

 As the act aims to address inflation and make healthcare more affordable, the ripple effects on pharmacies include changes in reimbursement, drug pricing, and payment models. In this landscape, Managed Health Care Associates, Inc. (MHA) is taking proactive measures to mitigate potential negative impacts on its LTC members and position them for success.

The IRA’s changes in Medicare reimbursement, along with new regulations regarding drug pricing and transparency, can lead to financial pressures for long-term care pharmacies. The risk of reduced profit margins, increased compliance costs, and shifts in prescription volume are among top concerns.

MHA, recognizing these challenges, has taken a leadership role in addressing these impacts, focusing on a comprehensive approach to safeguard its LTC members. Below are five key initiatives that illustrate how MHA is leading the way in supporting LTC pharmacies through these changes…

Read the full article